Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain

Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain

Victoria Neches García,1 Laura Amanda Vallejo-Aparicio,1 Afisi S Ismaila,2,3 Antoni Sicras-Mainar,4 Aram Sicras-Navarro,4 Cruz González,5 Rafael Cuervo,6 Soham Shukla,2 Marcos García-Peñuela6 1Market Access, GlaxoSmithKline, Madrid, Spain; 2Value Evidence and Outcomes, GlaxoSmithKline, Collegeville,...

Full description

Bibliographic Details
Main Authors: Neches García V, Vallejo-Aparicio LA, Ismaila AS, Sicras-Mainar A, Sicras-Navarro A, González C, Cuervo R, Shukla S, García-Peñuela M
Format: Article
Language:English
Published: Dove Medical Press 2022-09-01
Series:International Journal of COPD
Subjects:
inhaled corticosteroid withdrawal
copd
exacerbations
resource use
health costs
Online Access:https://www.dovepress.com/clinical-and-economic-impact-of-long-term-inhaled-corticosteroid-withd-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/clinical-and-economic-impact-of-long-term-inhaled-corticosteroid-withd-peer-reviewed-fulltext-article-COPD

Similar Items